Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Urine Cell Transcriptomes Implicate Specific Renal Inflammatory Pathways Associated With Difficult-to-Control Hypertension. | J Am Heart Assoc | 2023 | 36892045 | PubTator, text mining | PubMed |
| A multidimensional pan-cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma. | FASEB J | 2023 | 36884358 | PubTator, text mining | PubMed |
| What do we know about co-stimulatory and co-inhibitory immune checkpoint signals in ankylosing spondylitis? | Clin Exp Immunol | 2023 | 36883249 | PubTator, text mining | PubMed |
| CD24-associated ceRNA network reveals prognostic biomarkers in breast carcinoma. | Sci Rep | 2023 | 36882451 | PubTator, text mining | PubMed |
| Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology. | Front Pharmacol | 2023 | 36874011 | PubTator, text mining | PubMed |
| Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach. | Cancer Immunol Immunother | 2023 | 36869232 | PubTator, text mining | PubMed |
Identification and characterization of a novel molecular classification incorporating oxidative stress and metabolism-related genes for stomach adenocarcinoma in the framework of predictive, preventive, and personalized medicine. | Front Endocrinol (Lausanne) | 2023 | 36860371 | PubTator, text mining | PubMed |
| Identification of CD8 + T-Cell-Immune Cell Communications in Ileal Crohn's Disease. | Clin Transl Gastroenterol | 2023 | 36854061 | PubTator, text mining | PubMed |
Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2-/BCL6- Nonrearranged Small B-Cell Lymphoid Neoplasms as Follicular or Nodal Marginal Zone Lymphoma. | Mod Pathol | 2023 | 36853790 | PubTator, text mining | PubMed |
| Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms. | Vaccines (Basel) | 2023 | 36851285 | PubTator, text mining | PubMed |
| MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study. | Breast J | 2023 | 36846347 | PubTator, text mining | PubMed |
| A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma. | Front Oncol | 2023 | 36845727 | PubTator, text mining | PubMed |
| Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer. | Front Immunol | 2023 | 36845139 | PubTator, text mining | PubMed |
| The immune-metabolic crosstalk between CD3+C1q+TAM and CD8+T cells associated with relapse-free survival in HCC. | Front Immunol | 2023 | 36845133 | PubTator, text mining | PubMed |
| GAPDH Is a Novel Ferroptosis-Related Marker and Correlates with Immune Microenvironment in Lung Adenocarcinoma. | Metabolites | 2023 | 36837761 | PubTator, text mining | PubMed |
| Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances. | Genes (Basel) | 2023 | 36833303 | PubTator, text mining | PubMed |
| NKG2A Immune Checkpoint in Vδ2 T Cells: Emerging Application in Cancer Immunotherapy. | Cancers (Basel) | 2023 | 36831606 | PubTator, text mining | PubMed |
| Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer. | Biomolecules | 2023 | 36830717 | PubTator, text mining | PubMed |
| Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors. | Biology (Basel) | 2023 | 36829496 | PubTator, text mining | PubMed |
| Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models. | J Immunother Cancer | 2023 | 36822670 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=35